These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 39051211)

  • 21. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H;
    Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical manifestations of respiratory syncytial virus-associated encephalopathy in Fukushima, Japan.
    Kawasaki Y; Suyama K; Go H; Hosoya M
    Pediatr Int; 2019 Aug; 61(8):802-806. PubMed ID: 31257673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
    Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
    Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis.
    Shi T; Vennard S; Jasiewicz F; Brogden R; Nair H;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S17-S21. PubMed ID: 34522961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of surveillance case definitions for respiratory syncytial virus infections through the sentinel influenza surveillance system, Portugal, 2010 to 2018.
    Sáez-López E; Pechirra P; Costa I; Cristóvão P; Conde P; Machado A; Rodrigues AP; Guiomar R
    Euro Surveill; 2019 Nov; 24(45):. PubMed ID: 31718741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.
    Wang D; Bayliss S; Meads C
    Health Technol Assess; 2011 Jan; 15(5):iii-iv, 1-124. PubMed ID: 21281564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of respiratory syncytial virus diseases among under 5 children in Sub-Saharan Africa:
    Wada FW; Tadesse Boltena M; Howe R; Solomon FB; Feleke A; Seyoum T; Mulu A; Mihret A
    Heliyon; 2023 Dec; 9(12):e22211. PubMed ID: 38076137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis.
    Savic M; Penders Y; Shi T; Branche A; Pirçon JY
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13031. PubMed ID: 36369772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of coronavirus disease 2019 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis.
    Sabeena S; Ravishankar N; Robin S; Pillai SS
    Indian J Public Health; 2023; 67(2):284-291. PubMed ID: 37459026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America.
    Bardach A; Rey-Ares L; Cafferata ML; Cormick G; Romano M; Ruvinsky S; Savy V
    Rev Med Virol; 2014 Mar; 24(2):76-89. PubMed ID: 24757727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants.
    Li XL; Han J; Yan ZR; Zhang BW; Wang HY
    J Neurovirol; 2021 Aug; 27(4):638-643. PubMed ID: 34227046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.
    Tejada S; Martinez-Reviejo R; Karakoc HN; Peña-López Y; Manuel O; Rello J
    Adv Ther; 2022 Sep; 39(9):4037-4051. PubMed ID: 35876973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza.
    Atamna A; Babich T; Froimovici D; Yahav D; Sorek N; Ben-Zvi H; Leibovici L; Bishara J; Avni T
    Int J Infect Dis; 2021 Feb; 103():489-493. PubMed ID: 33249288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary function sequelae after respiratory syncytial virus lower respiratory tract infection in children: A systematic review.
    Verwey C; Nunes MC; Dangor Z; Madhi SA
    Pediatr Pulmonol; 2020 Jul; 55(7):1567-1583. PubMed ID: 32364320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
    Zhang S; Akmar LZ; Bailey F; Rath BA; Alchikh M; Schweiger B; Lucero MG; Nillos LT; Kyaw MH; Kieffer A; Tong S; Campbell H; Beutels P; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S680-S687. PubMed ID: 32227101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
    Chaw PS; Hua L; Cunningham S; Campbell H; Mikolajczyk R; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S620-S627. PubMed ID: 31825072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palivizumab and prevention of childhood respiratory syncytial viral infection: protocol for a systematic review and meta-analysis of breakthrough infections.
    Jun S; Sebastianski M; Featherstone R; Robinson J
    BMJ Open; 2019 Jul; 9(7):e029832. PubMed ID: 31340973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.
    Shi T; Balsells E; Wastnedge E; Singleton R; Rasmussen ZA; Zar HJ; Rath BA; Madhi SA; Campbell S; Vaccari LC; Bulkow LR; Thomas ED; Barnett W; Hoppe C; Campbell H; Nair H
    J Glob Health; 2015 Dec; 5(2):020416. PubMed ID: 26682048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating the evidence to support the establishment of a Respiratory Syncytial Virus surveillance system in Cameroon: A study protocol.
    Njuma Libwea J; Esso L; Njoh AA; Ngwa CH; Ngomba Armelle V; Bilounga Ndongo C; Etoundi Mballa GA; Nwaru BI; Weinberger D; Njouom R; Koulla-Shiro S
    PLoS One; 2024; 19(6):e0303468. PubMed ID: 38861519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.
    Sanders SL; Agwan S; Hassan M; van Driel ML; Del Mar CB
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009417. PubMed ID: 31446622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.